Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports First Quarter 2016 Results
May 3, 2016 4:16 PM EDTAUDUBON, Pa., May 03, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2016.
Worldwide sales increased 5.8% as reported to $139.3 million, or 6.2% on a constant currency basisFirst quarter net income increased 13.6% to $28.0 millionFully diluted earnings per share (EPS) increased 13.2% to $0.29Non-GAAP Adjusted EBITDA was 38.2% of salesCompany reiterates 2016 guidance for sales of $583 million and EPS of $1.20David Paul, Chairman and CEO said, First quarter sales were $139.3 million, a year-over-year increase of... More
